You're Doing Everything Right and Still Can't Detox. Here's Why.

GSTM1 encodes an enzyme that grabs onto environmental toxins, heavy metals, and carcinogens and attaches them to glutathione, a carrier molecule that escorts them out of your body. It’s one of your liver’s most important defenders against persistent pollutants.

The problem: roughly 50% of the population carries a GSTM1 null genotype, meaning they have a complete deletion of this gene. If you’re null, you’re missing this enzyme entirely, which cuts your ability to eliminate an entire class of toxins by about half. You’re not just slow at detox; a key pathway is simply absent.

This shows up as chemical sensitivity you can’t explain, problems with secondhand smoke or strong perfumes, fatigue that worsens after spending time in traffic or around pesticides, and a sense that your body is always fighting something invisible.

GSTP1 encodes another glutathione S-transferase that specializes in clearing oxidative stress byproducts and electrophilic compounds generated both from environmental exposures and your own metabolism. It works downstream of free radical damage to prevent that damage from accumulating further.

The Ile105Val variant, carried by roughly 35-40% of people, reduces this enzyme’s activity significantly. With the Val allele, your cells struggle to bind oxidative waste products and shuttle them out, which means oxidative damage lingers longer in your tissues. You’re generating the same amount of free radical damage as anyone else, but your cleanup crew is understaffed.

You notice this as persistent tiredness despite good sleep, brain fog that doesn’t lift, joint inflammation that flares unpredictably, and a nagging sense that your body is aging faster than it should be.

MTHFR controls methylation, a cellular process that’s essential for dozens of functions including gene regulation, neurotransmitter production, and DNA repair. It also plays a critical role in glutathione production, your body’s master antioxidant and heavy metal binder. Without sufficient methylation, glutathione production drops, and heavy metals like mercury, lead, and cadmium can’t be effectively eliminated.

The C677T variant, present in roughly 40% of people of European ancestry, reduces enzyme efficiency by 30-40%. This doesn’t just slow methylation; it creates a bottleneck in glutathione synthesis, which cascades into impaired detoxification of heavy metals across your entire system. Your body can’t build enough of its most powerful detox molecule.

You experience this as unexplained metal sensitivities (you feel worse after dental work, around copper pipes, or after eating fish), persistent fatigue despite supplementing, brain fog that worsens with certain exposures, and a feeling that you’re more chemically sensitive than your peers.

SOD2 encodes superoxide dismutase 2, an antioxidant enzyme that works specifically inside your mitochondria to neutralize free radicals before they damage the powerhouse of your cells. Every time your mitochondria burn fuel to make energy, they generate reactive oxygen species as a byproduct. SOD2 is the first line of defense against that damage.

The Val16Ala variant, carried by roughly 40% of people of European ancestry in the homozygous form, reduces SOD2 activity by approximately 30-40%. When you’re exposed to environmental toxins, heavy metals, or excess alcohol, your mitochondria generate more free radicals than SOD2 can handle, and oxidative damage accumulates inside your cells. Your energy production machinery gets slowly corroded.

This shows up as debilitating fatigue that’s out of proportion to your activity level, exercise that leaves you exhausted rather than energized, brain fog and poor focus especially after chemical exposures, and a creeping sense that your stamina is declining even though you’re young.

CYP1A2 is a phase I enzyme that activates polycyclic aromatic hydrocarbons (PAHs) found in cigarette smoke, grilled food, and air pollution, preparing them for phase II elimination. It’s a critical first step in breaking down these persistent environmental carcinogens so your body can process them further.

The Ile462Val variant, present in roughly 5-10% of people, alters how efficiently this enzyme processes these compounds. The changes can affect the rate at which you activate certain toxins, which may cause them to linger longer in your system or accumulate in liver tissue. Your phase I system isn’t working quite in sync with your phase II system, creating a traffic jam.

You experience this as unusual sensitivities to grilled or charred food, worsening fatigue after spending time around smoke or heavy traffic, chemical sensitivities that seem disproportionate to your exposure level, and a history of liver function tests that are slightly off normal.

NQO1 encodes NAD(P)H quinone oxidoreductase, a phase II enzyme that specializes in detoxifying quinones (oxidized compounds found in pollution and industrial exposures) and benzene metabolites. It’s particularly important for people exposed to urban air pollution, gas stations, dry cleaning fumes, or industrial environments.

The Pro187Ser variant, with prevalence ranging from 4-20% depending on ancestry, can completely eliminate NQO1 activity in people with certain genotypes. Without functional NQO1, your body can’t clear benzene derivatives or quinones effectively, which means these compounds accumulate in bone marrow, liver, and fatty tissues. These are exactly the exposures that most people dismiss as unavoidable background pollution.

This manifests as unexplained illnesses or infections that emerge after being near dry cleaning facilities, gas stations, or heavy traffic, persistent anemia or blood count abnormalities, chemical sensitivity that others don’t share, and a feeling of never quite recovering after chemical exposures.